Immunovia

About:

Immunovia is a diagnostics company that focuses on the early detection of pancreatic cancer through blood-based testing.

Website: http://immunovia.com

Twitter/X: immunovia

Top Investors: National Institutes of Health, EASME - EU Executive Agency for SMEs

Description:

Immunovia is a diagnostics company specializing in the early detection of pancreatic cancer. Immunovia conducts clinical trials and validation studies to ensure the accuracy and reliability of their tests. The company collaborates with medical institutions and research centers globally to validate its diagnostic tests and bring them to market. By focusing on early detection, Immunovia aims to significantly impact the treatment and management of pancreatic cancer, potentially improving survival rates. The company's innovative approach to using blood-based biomarkers could pave the way for early detection strategies in other cancers and complex diseases.